A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)

Inclusion Criteria (part I): * Evidence of peri-menopause (changes in the regular period in terms of irregularity in the length of the period, the time between periods, and the level of flow), or * Evidence of post-menopause (spontaneous amenorrhea over 12 months) Inclusion Criteria (part II): * Presence of moderate-to-severe menopause-related vasomotor symptoms (MR-VMS); Moderate: sensation of heat with sweating, able to continue activity; Severe: sensation of heat with sweating, causing cessation of activity) Exclusion Criteria (part I): * No evidence of peri-menopause or post-menopause, or * Women who are currently participating or have participated in menopause-related vasomotor symptoms (MR-VMS) clinical trials Exclusion Criteria (part II): * Subjects who are treated with tamoxifen, aromatase inhibitors or Gonadotropin-releasing hormone (GnRH) agonists/antagonists for cancer or any other medical condition, or * Subjects who have mild menopause-related vasomotor symptoms (MR-VMS) only